Navigation Links
TIGroup Names Dennis M. Smith as Chief Financial Officer
Date:9/26/2007

LOS ANGELES, Sept. 26 /PRNewswire-FirstCall/ -- TIGroup, Inc. (OTC Bulletin Board: TISG), a California-based financial solutions provider to the healthcare industry focused on ambulatory surgical centers (ASCs) and other businesses designed to deliver quality healthcare services outside of traditional hospital settings, today named Dennis M. Smith as the company's chief financial officer. He has served as a director on the company's board since 2001.

Smith was most recently chief executive officer of Cross Shore Acquisition Corporation, a special purpose acquisition company listed on the Alternative Investment Market of the London Stock Exchange. On August 29, 2007, Cross Shore completed the acquisition of Research Pharmaceutical Services, Inc. (RPS), a provider of integrated clinical development solutions to the bio- pharmaceutical industry. Smith continues to serve as a director of RPS.

Prior to Cross Shore, Smith co-founded and served as vice chairman and chief financial officer of Vsource, Inc., the predecessor to TIGroup. Through Vsource Asia, a subsidiary based in Malaysia, Vsource provides business process outsourcing solutions for Fortune 500 and Global 500 companies in the Asia-Pacific region. Following the sale of Vsource Asia in 2004, Smith served as chairman and chief executive officer of Vsource until July 2005. He continues to serve as a non-executive director, consultant and member of the board of Vsource Asia.

Smith lived and worked in Asia for 28 years. Prior to founding Vsource, he co-founded and served as general partner of ChinaVest, one of the earliest and largest independent private equity firms in Asia. In addition, he held senior positions in commercial and investment banking with First Chicago Corp. (now JPMorgan Chase) in Hong Kong, Singapore and the Philippines. He holds an MBA degree from Loyola University of Chicago.

TIGroup CEO David Hirschhorn said, "We are pleased to welcome Dennis to the company. His le
'/>"/>

SOURCE TIGroup, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Vietnamese Scientists Unravel Genetic Code Of Bird Flu Virus
2. Financial Allowances Being Offered To Poor Vietnamese HIV Carriers
3. Gene Bias: Onomastics of Shared Surnames among Men Reveals Genetic links
4. AIDS Funding Grants Dependant on Tracking Patients Names Efficiently
5. Health Minister Wants Names of Uncooperative Hospital Consultants
6. Chinese PLA Names Bogus Army Medical Bodies Selling Fake Drugs
7. Over 50 Vietnamese Girls Faint Due to Mass Hysteria
8. All U.S. States To Begin Names-Based Reporting of HIV Cases by End of 2007
9. Rajasthan Directs Doctors to Prescribe Medicines by Generic Names
10. GlaxoSmithKline - Changes Lamictal(R) Label Appearance and Packaging
11. Iodex goes to SmithKline Beecham consumer Healthcare
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/14/2008)... Also debuts TMR,09 campaign, IRVINE, Calif., O...poration (Pink Sheets: CGCP), a global leader of i...nd the market leader of surgical products for,tran...educational symposium,yesterday in conjunction wit...rapeutics (TCT) meeting in Washington, D.C., The ...
(Date:10/14/2008)... more than 500 accounts Company opening new PROMUS...ICK, Mass., Oct. 14 /PRNewswire-FirstCall/ -- Bost...unced estimated U.S. market shares for,September f...liminary data,from Millennium Research Group (MRG)...he healthcare sector., Based on the MRG data, the...
(Date:10/14/2008)... Leading Supplemental Insurance Company Encour... Employee Benefits , Chic...e , a leading provider of supplemental insurance, ...time to review employee benefits and recommends ,V...to help retain employees. These programs can be a ...
(Date:10/14/2008)...ctober 14 /PRNewswire/ -- Researchers at the Insti... started work on a 3.5 year,project to develop a n...hemical vapour deposition) diamond manufactured by...he field of CVD diamond synthesis and its,applicat...uld open up a raft of new,application areas in, fo...
Breaking Medicine News(10 mins):Health News:Cardiogenesis Announces Successful Educational Symposium Targeted at Cardiologists at the TCT Meeting in Washington, D.C. 2Health News:Cardiogenesis Announces Successful Educational Symposium Targeted at Cardiologists at the TCT Meeting in Washington, D.C. 3Health News:Cardiogenesis Announces Successful Educational Symposium Targeted at Cardiologists at the TCT Meeting in Washington, D.C. 4Health News:Boston Scientific Announces Drug-Eluting Stent Market Share Estimates for September and Third Quarter 2Health News:Boston Scientific Announces Drug-Eluting Stent Market Share Estimates for September and Third Quarter 3Health News:Boston Scientific Announces Drug-Eluting Stent Market Share Estimates for September and Third Quarter 4Health News:Combined Insurance Reports that Voluntary Programs Can Offer Employers a Cost Effective Way to Offer Benefits and Help Retain Employees 2Health News:Combined Insurance Reports that Voluntary Programs Can Offer Employers a Cost Effective Way to Offer Benefits and Help Retain Employees 3Health News:Combined Insurance Reports that Voluntary Programs Can Offer Employers a Cost Effective Way to Offer Benefits and Help Retain Employees 4Health News:Combined Insurance Reports that Voluntary Programs Can Offer Employers a Cost Effective Way to Offer Benefits and Help Retain Employees 5Health News:Novel Solid-State Laser Design Based on Synthetic Diamond From Element Six Opens up New Applications 2Health News:Novel Solid-State Laser Design Based on Synthetic Diamond From Element Six Opens up New Applications 3Health News:Novel Solid-State Laser Design Based on Synthetic Diamond From Element Six Opens up New Applications 4
...als of public health interventions can cost hundre...hers// in this week’s BMJ argue that, if the scien...ne. Randomised controlled trials are usually requ...emented. But in 2003, the BMJ published an article...
...ersity (LLU) shows that adding just a handful of p...xidation of blood lipids// , thus helping reduce t... this positive effect was in part due to the pecan...'Plant foods, including pecans, are rich sources o...
...dial tibial stress syndrome, better known as shin ... conducted// at the University of Messina in Messi...stress syndrome is one of many overuse lower leg i...and accounts for between 13.2% and 17.3% of all ru...
...t has become more common in aged people. Exercise ...h joint // replacement as a treatment for the cond...thritis Care & Research examined whether asking pa...r knee replacement surgery would help in restoring...
Other Medicine News:Health News:Antioxidant-Rich Pecans Protect Against Unhealthy Oxidation in the Body 2Health News:Does Exercise Before Hip Replacement Help? 2
(Date:10/14/2008)... 14 /PRNewswire-USNewswire/ -- The Michael J. Fox,...l of $2 million to five,research teams to speed de...ressed cognitive and mood-related symptoms of Park...oms, which range from problems with,executive func...ute plans),to dementia; depression, apathy and anx...
(Date:10/13/2008)... Stent with Polyzene(R)-F Surface Treatment Maximi...ogenicity, Need for Long-Term,Dual Antiplatelet Th...al investigators at today,s,"Innovative Devices an...nual Transcatheter Cardiovascular Therapeutics (TC...scular Research Foundation, presented,12-month fol...
(Date:10/13/2008)...s., Oct. 13 /- Facet Solutions, Inc. ...p on 20 patients from its US,IDE Pilot Study. The ...y,Index (ODI) scores, and an 80% reduction in Visu...eoff Pardo, President & CEO for Facet Solutions,a...s, which thus far not,only demonstrate significant...
(Date:10/10/2008)... MENLO PARK, Calif., Oct. 10 /PRNewswire-FirstCall...that it plans to present,long-term follow-up data ...,week at the Cardiovascular Research Foundation,s ...r Therapeutics (TCT) meeting in Washington, DC.,Th...esigned to investigate,the safety and efficacy of ...
Breaking Medicine Technology:Michael J. Fox Foundation Awards $2 Million for Research on Cognitive and Mood Symptoms of Parkinson's Disease 2Michael J. Fox Foundation Awards $2 Million for Research on Cognitive and Mood Symptoms of Parkinson's Disease 3Michael J. Fox Foundation Awards $2 Million for Research on Cognitive and Mood Symptoms of Parkinson's Disease 412-Month ATLANTA Trial Data Show Sustained Benefit of Catania(TM) Stent in Treatment of De Novo Coronary Lesions 212-Month ATLANTA Trial Data Show Sustained Benefit of Catania(TM) Stent in Treatment of De Novo Coronary Lesions 312-Month ATLANTA Trial Data Show Sustained Benefit of Catania(TM) Stent in Treatment of De Novo Coronary Lesions 4XTENT Announces Clinical Trial Data to be Presented at Annual Meeting of Transcatheter Cardiovascular Therapeutics Next Week 2GSA Selects Cascades Technologies Inc 28CTi 29 to Support USA gov 2431 1GSA Selects Cascades Technologies Inc 28CTi 29 to Support USA gov 2431 2FDA Approves Additional Dosage Strengths of Shires ADHD Treatment VYVANSE 28TM 29 28lisdexamfetamine dimesylate 29 Which May Help Physicians Tailor T 2429 1FDA Approves Additional Dosage Strengths of Shires ADHD Treatment VYVANSE 28TM 29 28lisdexamfetamine dimesylate 29 Which May Help Physicians Tailor T 2429 2FDA Approves Additional Dosage Strengths of Shires ADHD Treatment VYVANSE 28TM 29 28lisdexamfetamine dimesylate 29 Which May Help Physicians Tailor T 2429 3FDA Approves Additional Dosage Strengths of Shires ADHD Treatment VYVANSE 28TM 29 28lisdexamfetamine dimesylate 29 Which May Help Physicians Tailor T 2429 4FDA Approves Additional Dosage Strengths of Shires ADHD Treatment VYVANSE 28TM 29 28lisdexamfetamine dimesylate 29 Which May Help Physicians Tailor T 2429 5Kiwa Bio Tech Products Group Holds a Fertilizer Products Exhibition in Hebei 2427 1Kiwa Bio Tech Products Group Holds a Fertilizer Products Exhibition in Hebei 2427 2Kiwa Bio Tech Products Group Holds a Fertilizer Products Exhibition in Hebei 2427 3Tengion Launches Third Phase 2 Clinical Trial of Regenerated Human Bladder 1132 1Tengion Launches Third Phase 2 Clinical Trial of Regenerated Human Bladder 1132 2Tengion Launches Third Phase 2 Clinical Trial of Regenerated Human Bladder 1132 3Tengion Launches Third Phase 2 Clinical Trial of Regenerated Human Bladder 1132 4
...Mullerian Inhibiting Substance (MIS), also known a...glycoprotein dimer composed of two 72 kDa monomers...to the transforming growth factor-? (TGF-?) superf... and activin glycoproteins (2). All members of thi...
The STA Compact CT is a completely automated, benchtop hemostasis analyzer capable of performing clotting assays in random access mode. The system's unique method of sample management offers high thr
...Alpha Fetoprotein (AFP) is a 68 kDa protein, which...tal liver and yolk sac [1]. Human fetal serum AFP...n rates reach 19-26 g/min during mid-gestation (14...es of total fetal AFP continue to increase after m...
Compensating for movement is critical to weighing patients in wheelchairs. Thats why this scale has the exclusive technology to do just that. Extremely durable, with state-of-the-art technology, thes
Medicine Products: